Nasal Corticosteroid Therapy for Patients with Chronic Kidney Disease

Introduction to Nasal Corticosteroids

The American College of Allergy, Asthma, and Immunology recommends fluticasone propionate as the first-line nasal corticosteroid for patients with chronic kidney disease due to its minimal systemic absorption and no clinically significant HPA axis suppression at recommended doses 1

For patients with allergic rhinitis or chronic rhinosinusitis, the initial dose of fluticasone propionate is 200 mcg daily, with no dose adjustment needed for renal impairment 1
The European Respiratory Society suggests that mometasone furoate is a suitable second-line option, with a dosing regimen of 200 mcg once daily for adults 2

The American Academy of Otolaryngology suggests that among all intranasal corticosteroids studied, there are no significant differences in efficacy when comparing symptom score reductions, though all are superior to placebo 3, 4
Fluticasone propionate demonstrates no evidence of systemic effects or hypothalamic-pituitary-adrenal axis suppression at therapeutic doses, making it particularly safe for patients with impaired renal function 1

The European Rhinologic Society notes that nasal irrigation with corticosteroids shows greater improvement than spray in nasal blockage, drainage, and endoscopy scores at 12 months 3, 5
However, for patients with CKD without severe chronic rhinosinusitis or nasal polyps, standard spray formulation is sufficient and most practical 1

The American College of Allergy, Asthma, and Immunology recommends direct spray away from the nasal septum toward the outer wall of the nose to prevent septal perforation with long-term use 1, 2
Local irritation, epistaxis, and pharyngitis are the most common adverse effects, which are mild to moderate and can be minimized with proper spray technique 1, 2

Long-term treatment with nasal corticosteroids is effective and safe for patients with chronic rhinosinusitis, with studies demonstrating safety up to 52 weeks 6, 7, 2
The American Academy of Otolaryngology suggests continuing treatment indefinitely as maintenance therapy when clinically indicated, as there is no evidence of systemic toxicity with chronic use 2

The American Academy of Otolaryngology-Head and Neck Surgery recommends directing the spray toward the outer wall of the nose to prevent septal perforation with long-term use 8
The American Academy of Otolaryngology-Head and Neck Surgery suggests using the right hand for the left nostril and left hand for the right nostril to achieve proper angulation 8
The American Academy of Otolaryngology-Head and Neck Surgery advises looking downward by bending the neck toward the floor during administration 8
The American Academy of Otolaryngology-Head and Neck Surgery recommends avoiding sniffing hard after spraying 8

The European Rhinologic Society recommends adding nasal saline irrigation with isotonic saline or Ringer's lactate to intranasal corticosteroid therapy for enhanced symptom relief in CKD patients 9
The American Academy of Otolaryngology-Head and Neck Surgery suggests that large-volume nasal irrigation is more effective than saline spray for expelling secretions and improving quality of life 8
The European Rhinologic Society notes that saline irrigation has minimal side effects and no systemic absorption concerns, making it ideal for CKD patients 10
The American Academy of Otolaryngology-Head and Neck Surgery recommends the combination of intranasal corticosteroids plus saline irrigation for superior outcomes compared to either therapy alone 8

The European Rhinologic Society advises against using nasal decongestants regularly in CKD patients, as they cause rebound congestion and have no role in chronic management 9
The European Rhinologic Society recommends avoiding hypertonic saline solutions due to increased side effects without additional benefit over isotonic solutions 10